MidAtlantic AIDS Education and Training Center: Events

Trainings & Events
Headquarters & Regional Partner Sites
Special Projects
- SPNS
- Ryan White Parts C & D Collaborative
Resources
- National HIV Resources
- MAAETC Program Materials
About
- Services
  - Overview
  - Administration and Structure
- Contact
  - Contact Form
  - Contact Us
Contact Us
- Contact Form

BPHC Prevention Community of Practice - Peer Discussion #1

Details

Starts at: September 14, 2023 12:00pm ET

Ends at: September 14, 2023 1:00pm ET

Free Admission

Invite Only: Password Protected

Description

The Prevention Community of Practice (CoP) provides an opportunity for Federally Qualified Community Health Centers (FQHCs) in Philadelphia, Baltimore and Washington, DC to learn from each other regarding increasing HIV testing, diagnosis and prevention, including the provision of pre-exposure prophylaxis (PrEP). Health Resources and Services Administration's (HRSA)Bureau of Primary Care and HIV/AIDS Bureau are supporting this initiative to partner with Ending the HIV Epidemic-funded FQHCs in the MAAETC region.

The participants for this project have already been selected. If you are not currently a part of the program but are interested in similar trainings or events, pleas contact us at maaetc@pitt.edu.

Intended Audience

Ending the HIV Epidemic-funded FQHCs in the MAAETC region

Contact

Person: Debra D'alessandro ddalessandro@healthfederation.org

Targeted Populations

A variety of the listed populations will be discussed at this event.

Young Adults (ages 18 to 24)
Black or African American
Women
Gay, lesbian, bisexual

Topics

A variety of the listed topics will be discussed at this event.

Pre-exposure prophylaxis (PrEP)
Organizational needs assessment
Quality Improvement
Team-based care (i.e. interprofessional training)

MIDATLANTIC AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,917,621 with 0% financed with non-governmental sources. The contents in this presentation are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.